Argenx raises $1.1 billion in gross proceeds in a global offering

Regulated information — inside information     july 18, 2023, 9:20 pm et july 19, 2023, 3:20 am cet   amsterdam, the netherlands — argenx se (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced today the pricing of a global offering of ordinary shares, which may be represented by american depository shares (“adss”). the global offering is comprised of an offering of ordinary shares represented by adss in the united states and certain other countries outside of the european economic area and a simultaneous private placement of ordinary shares in the european economic area and the united kingdom.
ARGX Ratings Summary
ARGX Quant Ranking